FDA Investigator Emily E Smith

Emily E Smith has conducted inspections on 153 sites in 2 countries as of 15 Jan 2008. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
153
Last Inspection Date:
15 Jan 2008
Investigator Role:
FDA Investigator
Redica ID:
100009061
Countries of Inspections:
United States of America, South Africa
FDA Investigators that have inspected at least one site in common with Emily E Smith:
Abby Lmozeke Baker, Abraham M Maekele, Althea A Williams, Anetra E Wyatt, Anna E Fain, Anthony D Peterson, Barbara D Wright, Barbara S Manson, Bonnie E Conley, Bonnie E Pierson, Brian A Graves, Brian S Lynch, Brittany N Ross, Carolyn E Barney, Charles N Dupont, Charvais S Bogan, Charvais S Hill, Cherie T Parker, Cheryl G Scott, Cheryl L Watson, Christie B Rice, Christophe L Boulmay, Christopher J Adams, Claire M Minden, Cody D Rickman, Cynthia L Medlin, Dana M Klimavicz, Danielle M Maddox, David R Heiar, Demario L Walls, Dolores Harper, Donna D Gallien, MPH, Dr. Koffi A Amegadje, Eddie J Rigsby, Elizabeth D Connell, Erica L Sullivan, Erica M Katherine, Erika M Wilkerson, Ezra M Taylor, Fabian Nchaparro Rodriguez, Fatimah Omar, Francis A Guidry, Frank Flores, George J Flynn, Gloria J Horner, Holly I Hall, Jacquelyn Bradford, Javelle P Spann, Jean A Peeples, Jessica A Stephens, Joan A Loreng, Juanelma H Palmer, June P Page, Karen Gale Sego, Karen R Smallwood, Kari L Batey, Karl D Hezel, Kate E Jesse, Kayler L Hudson, Kellie R Riggs, Kenneth R Merritt, Kimberly Cdelk Brooks, Kimberly L Mcmillan, Konsuela Y Glass, Krista W Whitten, Lacey J Chessor, Laressa R Gray, Laura E Garcia, Laura L Staples, Lawrence A Butler, LCDR Randall L Morris, Leena Thomas, Leon T Morgan, Llopis, Marcus L Head, Margaret E Slimbach, Markeesa M Scales, Marvin D Jones, Mary A Millner, Melanie L Drayton, Meocha V Whaley, Michael R Duran, Michael T Nehring, Monty C Mcintyre, Myla T Collins, Natasha N Mccants, Pamela M Thomas, Patricia S Smith, Patrick C Dooley, Randy L Clarida, Richard J Bashay, Robert E Hultman, Samantha J Bradley, Samantha J Pinizzotto, D V M, Samuel A Hamblin, Sandy L Atkins, Saundrea A Munroe, Shayla G Turnipseed, Shirhonda D Thorn, Shondra N Gipson, Stephanie A Cochran, Stephanie Mangigian, MS/OSH, RN, Steven D Dittert, Tamira D Wesley, Tammara D Perry, Thomas O Morgan, Thomas R Stanley, Tiana M Mckinley, Traci M Armand, Travis E Chapman, Wendy R Blame, Whitney M White, William P Chatham, Zachary J Conlin, Zada L Giles

Emily E Smith's Documents

Publish Date Document Type Title
July, 2001 EIR Stewart-Jackson Pharmacal Inc - EIR, 2001-07-18
April, 2004 FDA 483 Bayer Healthcare, LLC - Form 483, 2004-04-14
February, 2000 EIR Alpha Therapeutic Corporation - EIR, 2000-02-02
December, 2000 EIR Alpha Therapeutic Corporation - EIR, 2000-12-08
December, 2000 FDA 483 Alpha Therapeutic Corporation - Form 483, 2000-12-08
December, 2004 FDA 483 Valerie K Arnold MD - Form 483, 2004-12-08
July, 2001 FDA 483 Stewart-Jackson Pharmacal Inc - Form 483, 2001-07-18
June, 2000 EIR Gem A Division of Diamond Products - EIR, 2000-06-14
December, 2004 EIR Valerie K Arnold MD - EIR, 2004-12-08
September, 2006 FDA 483 Wright Medical Technology Inc - Form 483, 2006-09-15
June, 2002 EIR United Donor Services - EIR, 2002-06-27
August, 2004 FDA 483 Memphi Rx Inc - Form 483, 2004-08-24
August, 2001 FDA 483 PMC Biogenix, Inc. - Form 483, 2001-08-06
October, 2007 EIR Lora J. McGill, M.D., PI - EIR, 2007-10-18
March, 2005 FDA 483 Schwartzberg, Lee S. - Form 483, 2005-03-08
February, 2000 FDA 483 Response Alpha Therapeutic Corporation - Form 483R, 2000-02-17
February, 2000 FDA 483 Alpha Therapeutic Corporation - Form 483, 2000-02-02
June, 2000 FDA 483 Gem A Division of Diamond Products - Form 483, 2000-06-14
March, 2005 EIR Schwartzberg, Lee S. - EIR, 2005-03-08
October, 2001 EIR Rx PAK - EIR, 2001-10-31
September, 2003 EIR West TN Regional Blood Center, dba Lifeline Blood Services - EIR, 2003-09-15
September, 2002 FDA 483 Stewart-Jackson Pharmacal Inc - Form 483, 2002-09-06
December, 2000 EIR Rx PAK - EIR, 2000-12-19

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more